The inv(16) and related t(16;16) are found in 10% of all cases with de novo acute myeloid leukemia. In these rearrangements the core binding factor b (CBFB) gene on 16q22 is fused to the smooth muscle myosin heavy chain gene (MYH11) on 16p13. To gain insight into the mechanisms causing the inv(16) we have analysed 24 genomic CBFB-MYH11 breakpoints. All breakpoints in CBFB are located in a 15-Kb intron. More than 50% of the sequenced 6.2 Kb of this intron consists of human repetitive elements. Twenty-one of the 24 breakpoints in MYH11 are located in a 370-bp intron. The remaining three breakpoints in MYH11 are located more upstream. The localization of three breakpoints adjacent to a V(D)J recombinase signal sequence in MYH11 suggests a V(D)J recombinase-mediated rearrangement in these cases. V(D)J recombinase-associated characteristics (small nucleotide deletions and insertions of random nucleotides) were detected in six other cases. CBFB and MYH11 duplications were detected in four of six cases tested.
Introduction
The inv(16) [inv(16)(p13q22)] and related t(16;16) [t(16;16)(p13;q22) ] are associated with acute myeloid leukemia (AML) type M4 Eo (Le Beau et al., 1983) . These rearrangements lead to the disruption of the core binding factor b (CBFB) gene on 16q22 and of the smooth muscle myosin heavy chain gene (MYH11) on chromosome 16p13, resulting in a CBFB-MYH11 fusion gene (Liu et al., 1993) . CBFB codes for the bunit of the heterodimeric transcription factor CBF (also known as PEBP2), involved in myeloid and T-cell gene regulation Ito, 1996; Speck and Stacy, 1995) . Recent evidence suggests that the CBFb-MYH11 fusion protein contributes to the malignant transformation in a dominant-negative fashion by interfering with normal CBF functioning (Castilla et al., 1996) . Several chimeric, and alternatively spliced, CBFB-MYH11 transcripts have been identi®ed with reverse transcriptase-polymerase chain reaction (RT ± PCR). Interestingly, one fusion transcript (type A), is found in 88% of the cases, whereas in the remaining 12% fusion transcripts with longer MYH11 domains are found (Liu et al., 1993 Claxton et al., 1994; HeÂ bert et al., 1994; Shurtle et al., 1995; Poirel et al., 1995; van der Reijden et al., 1995) . To gain insight into the mechanisms causing the key mutation of inv(16) in AML M4 Eo and the odd distribution of the detected fusion transcripts, the CBFB and MYH11 major breakpoint cluster regions were subcloned and partially sequenced. We show that the breakpoints leading to the common fusion transcript type A are located in a 15-Kb CBFB and a 370-bp MYH11 intron and present the breakpoints from 24 inv(16) patients. Implications of the breakpoint clustering for the diagnosis of the inv(16) and detection of minimal residual disease by ampli®cation of genomic breakpoint regions and mechanisms underlying the AML M4 Eo associated rearrangements are discussed.
Results

Cloning and sequence analysis of CBFB intron 5
Previous studies showed that six of six tested inv(16) breakpoints in CBFB were located in a region spanned by one cosmid (LA4-1, Liu et al., 1993) . By partially subcloning and sequencing cosmid LA4-1, as well as establishing the BglII restriction map, we were able to identify two consecutive CBFB exons (designated as exons 5 and 6 based upon mouse homology, Ogawa et al., 1993; Wang et al., 1993) that are separated by a 15-Kb intron (Figure 1a) . The 3' end of exon 5 is at CBFB cDNA position 526. We recently showed that the last 31 nucleotides of exon 5 can be alternatively spliced, leading to two CBFB-MYH11 transcripts in one and the same patient, in which CBFB is either fused at position 495 or 526 to MYH11 van der Reijden et al., 1995) . Based on these data we concluded that the genomic breakpoints were expected to lie in the 15-Kb intron downstream of CBFB exon 5 ( Figure 1a ). Of these 15 Kb we have sequenced 6.2 Kb, to date. Analysis of the sequenced parts of this intron (intron 5) showed homology to various repetitive sequences: 12 Alu, one LINE-1 (Smit et al., 1995b) and one MIR (Smit et al., 1995a) Table 1 and surrounding CBFB sequences of the breakpoints are given in Figure 1b) . CBFB exons 5 and 6 are drawn as black boxes. Sequenced parts are indicated by solid lines and were obtained by sequencing cosmid LA4-1 subclones (Liu et al., 1993) Smit et al., 1995b) and MIR (downstream box, 101 bp, Smit et al., 1995a) repeats. Positions of primers used for the ampli®cation of genomic breakpoints (Table 2) are indicated with arrowheads (not shown to scale). Bg=BglII; C=centromeric; T=telomeric (b) CBFB intron 5 sequences surrounding genomic breakpoints of 18 inv(16) cases. Lanes a through p are non-overlapping, but are ordered 5' to 3' in CBFB intron 5 (Figure 1a ). Breakpoints are indicated by vertical arrowheads (where the arrowhead is positioned directly above a base, the breakpoint can lie on either side of that base). Numbers refer to cases in Figures 1 and 2 and Table 1 . V(D)J hepta-and nonamer homologous sequences are in bold and are detected near 12 of the 18 analysed breakpoints (matching sequences are 55 per heptamer and 57 per nonamer, except lane e: six matching bases with nonamer consensus sequence) of repetitive elements. In addition, several hepta-and nonamer sequences implicated in V(D)J recombination were identi®ed (Figure 1b, m, o and p) . No other known sequences implicated in illegitimate recombination, such as purine-pyrimidine tracts or topoisomerase-or w-like consensus sequences, were identi®ed.
Cloning and sequence analysis of MYH11 intron 30
We reported the cloning of a 6.9-Kb BamHI fragment (clone B1) spanning the MYH11 breakpoints in all of ®ve inv(16) patients tested in earlier studies . Clone B1 detects MYH11 DNA rearrangements in approximately 95% of all inv(16)/ t(16;16) cases (van der Reijden et al., 1996) . Subcloning and sequence analysis of clone B1 allowed us to identify and localize nine contiguous MYH11 exons in this fragment (Figure 2a ). Comparing our sequencing results from clone B1 to the MYH11 coding sequences, we determined that the genomic MYH11 breakpoints (leading to the common CBFB-MYH11 fusion transcript type A) must occur within a 370-bp intron (MYH11 intron 30, Figure 2a , see Note added in proof). The ®rst exon downstream of intron 30 starts at MYH11 cDNA position 1921, corresponding with the MYH11 junction at this position, as found in the type A CBFB-MYH11 fusion transcript (Liu et al., 1993) . The intron sequence shows no signi®cant homology to known sequences, with the exception of two small regions that are homologous to class Alu-J and Alu-Sb sequences (Figure 2b ). However, these Alu sequences are not homologous to the CBFB Alu sequences. A 10-bp region (pos 61 ± 70) in the Alu-J homologous sequence is inversely repeated at position 132 ± 141, as well as other, smaller, repeated and inversely repeated sequences at other positions ( Figure 2b ). MYH11 intron 30 contains two heptaand three nonamer sequences associated with V(D)J recombination. The most upstream nona-and heptamer sequences are spaced 23 bp apart and are positioned relative to each other in such a way that they form a perfect V(D)J recombinase signal sequence (RSS, Figure 2c , Gellert, 1992) . No other sequences implicated in illegitimate recombination were identi®ed in intron 30.
Subcloning and analysis of genomic inv(16) breakpoints
To obtain genomic inv(16) breakpoints, a bacteriophage library of case 3 (Table 1 ) was constructed and screened using clone B1 (van der as a probe (Figure 2a ). An aberrant 0.6-Kb XhoI ± SmaI fragment (compared to wild type MYH11 restriction fragments) from a positive clone, most likely containing the CBFB-MYH11 junction, was subcloned and sequenced. Sequence analysis showed a precise joining of CBFB to MYH11 sequences ( Table  1) . The breakpoints are located in CBFB intron 5 and MYH11 intron 30 (Figures 1a and 2a, respectively) . The genomic breakpoint from case 22 (Table 1) , cloned in the previously reported cosmid CC19 (Liu et al., 1993) , was isolated and characterized in an analogous way as that from case 3. A precise joining of CBFB to MYH11 sequences was also observed in this case ( Table 1) . The CBFB breakpoint is located in intron 5, and the MYH11 breakpoint is located in a 5.5 Kb intron (see Note added in proof).
Ampli®cation and analysis of genomic inv(16) breakpoints
Because MYH11 intron 30 is relatively small (370 bp), we set up a PCR using one MYH11 primer in combination with obtained CBFB primers to amplify genomic CBFB-MYH11 breakpoint regions. Using DNA from inv(16) patients that were previously shown to carry the transcript type A (Liu et al., 1993; van der Reijden et al., 1995 van der Reijden et al., , 1996 , we ampli®ed and sequenced the breakpoint regions in 22 of 41 cases tested. A precise joining of CBFB and MYH11 sequences was observed in 15 cases (Table 1 ). An insertion of 3 and 9 bp of unknown origin at the breakpoints are present in cases 15 and 20, respectively. In case 17, a 16-bp CBFB fragment that starts 25 bp downstream from the breakpoint, is present at the breakpoint as an inverted repeat (Table 1, Figure 3 ). In the remaining six cases (cases 1, 5, 6, 8, 12 and 21) the break in CBFB occurs in an area outside the sequences we have obtained to date. Because these sequences are unknown, no information about insertions can be obtained. The MYH11 breakpoints in these cases are located at the junction of non-homologous to homologous MYH11 intron 30 sequences.
The positions of MYH11 breakpoints in intron 30 are given in Figure 2b . Interestingly, three breakpoints are located adjacent to the V(D)J RSS (cases 3 ± 5). The CBFB breakpoints in cases 3 and 4 are only 42 bp apart, and are located near two V(D)J nonamer consensus sequences ( Figure 1b , lane b). The remaining case (case 5) breaks CBFB in an area for which the wild type sequences are unknown. The MYH11 breakpoints in cases 6 ± 22 are located further downstream in MYH11 intron 30, and no clear organization of these breakpoints with respect to the hepta-and nonamer sequences is observed (Figure 2b ). The remaining breakpoints in MYH11 intron 30 (cases 1 and 2) are located within the ®rst 40 bases of intron 30. Surprisingly, the MYH11 breakpoints in two patients are located near the 5' end of the exon preceding MYH11 intron 30. One of these is located 5 bp upstream, and the other 5 bp downstream, of the intron-exon boundary (MYH11 cDNA position 1708, case 23 and 24, respectively, Table 1, Figure 2a) . The predominantly detected CBFB-MYH11 fusion transcript in these cases is type A (not shown). The location and surrounding sequences (if known) of the breakpoints in CBFB intron 5 are given in Figure 1a and b, respectively. Comparison of CBFB sequences surrounding the dierent breakpoints did not reveal any common sequence motifs apart from numerous hepta-and nonamer sequences associated with V(D)J recombination (Figure 1b) . The CBFB breakpoints map in as well as outside the repetitive elements (Figure 1a ).
Ampli®cation and analysis of reciprocal breakpoints
To amplify the derivative q-arm breakpoint regions, CBFB primers based on the available sequence data were used ( Figure 1a , Table 2 ). The reciprocal MYH11-CBFB breakpoint regions were ampli®ed and (Gellert, 1992) are indicated by black bars. The percentage above the two non-matching bases indicate the degree of conservation sequenced in six of 10 patients tested. In four of these cases an insertion of random nucleotides was detected (cases 3, 4, 13 and 19, Figure 4 , Table 1 ). Comparison of the q-to p-arm breakpoints revealed frequent additional small nucleotide deletions (three out of six cases) as well as duplications (four out of six six cases) of CBFB and MYH11 sequences. In the cases 11 and 19, respectively, six and two MYH11-derived bases are deleted, whereas in case 18, four CBFB-derived bases are deleted and four MYH11-derived bases are duplicated (Table 1, Figure 4 ). In the cases 3 and 13 a duplication of, respectively, ®ve and 192 CBFBderived bases was observed, whereas in the remaining case (case 4) a duplication of four MYH11-derived bases was detected (Table 1, Figure 4 ).
Discussion
Although several dierent in-frame CBFB-MYH11 fusion transcripts in patients with inv(16)/t(16;16) and AML have been detected, the fusion transcript with the smallest MYH11 tail (type A) is present in 88% of all reported cases. In this study we show that the genomic breakpoints, leading to the formation of transcript type A, are clustered in a 15-Kb CBFB (intron 5) and 370-bp MYH11 (intron 30) region. The genomic CBFB-MYH11 breakpoint regions from 22 inv(16) patients were ampli®ed by PCR and sequenced. The breakpoint regions of two additional inv(16) patients (one with transcript type A and one with type E) were cloned and sequenced.
The frequent inclusion of CBFB coding sequences up to, and including, exon 5 in CBFB-MYH11 fusion transcripts (98%), suggests that the coding information in exon 5 is essential for leukemogenesis. Should this be the case, the localization of the genomic breakpoints in the 15-Kb CBFB intron 5 is explained. Intron 5 contains many repeats that are found near chromosomal breakpoints detected in hematological malignancies (Papadopoulos et al., 1990; Ohno et al., 1993; Schichman et al., 1994; Dong et al., 1995; Von Lindern et al., 1992) . Although their contribution to rearrangements is still unknown, they may cause genetic instability. As the breakpoints in MYH11 are not located near repetitive elements, it is, however, unlikely that they are caused by homologous recombination. The 370-bp MYH11 intron 30 is located in a 6.9-Kb BamHI fragment (Figure 2a) . Genomic breakpoints in eight of the nine introns in this fragment predict inframe MYH11 cDNA junctions. Remarkably, the majority of breakpoints are clustered in the 370-bp (Liu et al., 1993; van der Reijden et al., 1995 van der Reijden et al., , 1996 . All patients carry CBFB-MYH11 fusion transcript type A, except for case 22 (fusion type E). CBFB-MYH11 breakpoint consists of upstream CBFB and downstream MYH11 sequences, MYH11-CBFB breakpoint vice versa. Asterisks (*) indicate that surrounding CBFB sequences are unknown and MYH11 breakpoints in these cases are based on the junction of nonhomologous to MYH11 homologous sequences. PJ=precise joining of CBFB and MYH11 sequences; hb=homologous base at the breakpoint junction; Ldel=large deletion proximal of p-arm breakpoint present (450 Kb); blanks indicate not done; hyphen (-)=ampli®cation of reciprocal breakpoint is negative; ins=insertion of random nucleotides; (Table 1) . CBFB intron 5 sequences are in capital letters, MYH11 intron 30 sequences in lower case and the inversely inserted 16 CBFB-derived bases are in bold and underlined MYH11 intron 30 (Figure 2a ). This clustering may be the result of a selection, in which only the transcript type A derived fusion protein leads to leukemogenesis, with the exception of a few fusion proteins with longer MYH11 tails. At the other hand, the breakpoint clustering may be explained by the presence of a recombinational hot spot. No sequences implicated in illegitimate recombination, such as purine-pyrimidine tracts or topoisomerase-or w-like consensus sequences, were identi®ed in the MYH11 intron 30. Although seven pentamer sequences (CTGGG and CTGAG or their complementary sequences) implicated in isotype class switching are present (not indicated in Figure 2b ), they are not repeated as in a normal isotype class switch site. Therefore, their contribution to an isotype class switch mediated recombination is unlikely. The presence of the inverted repeats in MYH11 intron 30 and the random distribution of breakpoints with regard to these repeats (Figure 2b) does not explain the breakpoint clustering either. MYH11 intron 30 does contain a V(D)J RSS, consisting of a conserved hepta-and nonamer sequence, separated by a 23-bp spacer (Figure 2c ). The location of breakpoints next to this RSS in three cases (cases 3 ± 5) suggests a V(D)J recombinase-mediated rearrangement. CBFB intron 5 contains several V(D)J hepta-and nonamer sequences but is devoid of any V(D)J RSS, formally implying that CBFB breakpoints may not be the result of V(D)J recombination. At the other hand, the detected characteristics of V(D)J recombination (small nucleotide deletions and/or insertions) in six additional cases (Table 1) , are suggestive of V(D)J recombination involvement. The insertion of random nucleotides is probably caused by terminal deoxynucleotidyl transferase (TdT), because TdT expression has previously been detected in inv(16) cell immunophenotyping experiments (Adriaansen et al., 1993) . The relevance of the vicinity of the V(D)J consensus sequences and the ®nding of the inserted nucleotides for the inv(16) rearrangements remains to be studied further.
Comparison of derivative p-and q-arm breakpoints showed CBFB and MYH11 duplications in four of six (67%) cases (cases 3, 4, 13 and 18, Figure 4 ). How these duplications come about is unclear. Ampli®cation of the reciprocal MYH11-CBFB breakpoint regions with PCR was negative in four of ten cases tested (Table 1) . This is probably due to a deletion of sequences proximal to the p-and/or q-arm breakpoints Liu et al., 1993; Kuss et al., 1994; Marlton et al., 1995; van der Reijden et al., 1996) . Fluorescence in situ hybridization, using cosmids located 50 Kb proximal to the MYH11 breakpoint region, indeed showed a deletion in two cases tested (cases 7 and 16, Table 1 , FISH results not shown, van der Reijden et al., 1996) . The fact that no reciprocal breakpoint is ampli®ed in the cases with a deletion, suggests that the deletions extend to the p-arm breakpoint, and that in these cases a complex rearrangement with a simultaneous inversion and deletion may have occurred (Marlton et al., 1995; van der Reijden et al., 1996) . An even more complex rearrangement in which 16 CBFB-derived bases have been inversely inserted is detected in case 17 (Figure 3 ). It is unclear via which mechanism the 16 bp have been inserted, but comparison of this complex rearrangement with the other cases suggests that the inversions occur through a variety of mechanisms.
In two cases with fusion transcript type A (cases 23 and 24) the breakpoints are not located in MYH11 intron 30, but near the 5' end of the exon preceding this intron (Figure 2a) . In case 23 the breakpoint is located 5 bp upstream, and in the other case (case 24) 5 bp downstream, of the intron-exon boundary ( Figure   Figure 4 Comparison of CBFB-MYH11 and MYH11-CBFB sequences revealing CBFB and MYH11 deletions and duplications (see also Table 1 ). CBFB sequences are in capital letters, MYH11 sequences are in lower case, insertions are in italics, deletions are underlined, and duplications are in bold. Note that the insertion of a c in case 3 could also be called as an MYH11 duplication; The X in case 13 represents 182 CBFB-derived bases. Note that the ®rst two bases, upstream of the 4 bp duplicated MYH11 region in case 4, are homologous between CBFB and MYH11. Therefore, it is also possible that these are MYH11-derived bases and the rearrangement consequently then consists of a 6 bp MYH11-derived duplication (ctaatc) and a 2 bp CBFB deletion (CT) Figure 5 Genomic and cDNA breakpoints of case 24 near MYH11 cDNA position 1708. CBFB sequences are in capitals, MYH11 sequences in lower case, and coding sequences are in bold. CBFB and MYH11 cDNA positions are according to Liu et al. (1993) and Matsuoka et al. (1993) , respectively. The nucleotides ag (underlined) at MYH11 cDNA position 1713 ± 1714 serve as cryptic splice acceptor site explaining the MYH11 junction at position 1715 in the cDNA fusion (van der Reijden et al., 1995) 2a, MYH11 cDNA position 1708). In case 23 no fusion transcript with a junction at MYH11 cDNA position 1708 could be detected but in the other case (case 24), we previously showed the presence of a second, alternatively spliced fusion transcript (MYH11 cDNA fusion at 1715, Figure 5 , van der Reijden et al., 1995) . The nucleotides AG at MYH11 cDNA positions 1713 ± 1714 apparently serve as a cryptic splice acceptor site, accounting for the second transcript in this patient. Both cases illustrate that genomic breakpoints outside MYH11 intron 30 can also result in the formation of transcript type A and the concomitant leukemia.
The primers described in this paper allow a rapid and easy ampli®cation of genomic inv(16) breakpoint regions. Our ongoing sequence analysis of CBFB intron 5 should eventually identify a primer set with which all genomic breakpoint regions can be ampli®ed from inv(16) patients with transcript type A. Because this transcript is detected in 88% of all inv(16)/t(16;16) cases, the ampli®cation of inv(16) breakpoint regions with PCR may then become a way to diagnose patients quickly, but also facilitates the detection of minimal residual disease. This can be done in a quantitative way on the DNA level, without the limitations imposed by fusion transcript stability and the expression-dependent detection on the RNA level using RT ± PCR.
Materials and methods
Patient samples
Fresh or cryopreserved viable cells from patients were obtained from the Division Autonome de GeÂ neÂ tique MeÂ dicale, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (cases 2, 4, 7 ± 9, 16, 18 and 23, (Yanagisawa et al., 1991) .
Cosmid DNA subcloning
To obtain CBFB intron 5 subclones, ®rst a BglII and HindIII restriction map of the cosmids LA2-2 and LA4-1 (Liu et al., 1993 , containing CBFB intron 5) was generated as described previously (Wijmenga et al., 1993) . The cosmids were digested with the appropriate restriction enzymes and subcloned into the linearized plasmid vectors pKNUN1 (Dauwerse et al., 1989) or pBS-KS (Stratagene).
Inv(16) breakpoint cloning
Genomic DNA of case 3 (Table 1) was digested with BamHI and cloned in BamHI digested LambdaDASHII (Stratagene) arms and subsequently used to infect E. coli XL1 Blue MRA according to the manufactures instructions. 800.000 plaques were screened with the 6.9 Kb MYH11 probe B1 (van der Reijden et al., 1993, Figure  2a ). The inserts of two positive phages (both 14 Kb) were BamHI excised and cloned in the BamHI linearized and dephosphorylated plasmid vector pKNUN1 (Dauwerse et al., 1989) . The inserts were SmaI and XhoI digested and a 0.6 Kb aberrant XhoI ± SmaI fragment (as compared to wild type fragments) most likely containing the patient's inv(16) breakpoint was cloned in the SmaI ± XhoI linearized vector pKNUN1 (Dauwerse et al., 1989) . Sequence analysis showed a precise joining of CBFB to MYH11 sequences. The genomic breakpoint of case 22 (Table 1) was previously cloned in the cosmid CC19 (Liu et al., 1993 ). An aberrant 2 Kb BglII fragment from cosmid CC19 (as compared to wild fragments) most likely containing the patient's inv(16) breakpoint was subcloned into pBS-KS (Stratagene). Sequence analysis showed a precise joining of CBFB to MYH11 sequences.
Ampli®cation of genomic inv(16) breakpoints
Genomic patient DNA was isolated from fresh or cryopreserved bone marrow or peripheral blood cells by using standard protocols. CBFB-MYH11 genomic breakpoint ampli®cations were performed by using MYH11 primer mi or mo (Table 2, Figure 2a ) in combination with one of the CBFB primers cg, ica, icd, ich, icl, icm, ics or icv (Table 2, Figure 1a ) and 100 ± 300 ng genomic patient DNA as described previously (van der Reijden et al., 1995) , with the exception that extension periods at 728C were varied between 1.0 ± 2.5 min. MYH11-CBFB genomic breakpoint ampli®cations were identically performed as for CBFB-MYH11 ampli®cations except for that MYH11 primer ml (Table 2, Figure 2a ) in combination with either one of the CBFB primers ck, icg, icp, icq or icu (Table 2, Figure 1a ) were used. To obtain higher PCR product yields, second round PCRs using identical CBFB, but nested MYH11 primers (ima, imb or mo, Table 2, Figure  2a ) were performed, using 1 ml of the primary PCR and identical ®rst round PCR conditions.
Sequence reactions
Clones were sequenced using a T7 sequencing kit (Pharmacia) or an ABI 373A DNA sequencer (Applied Biosystems), according to the manufacturers protocols. Clone/patient-derived PCR products were either subcloned in the PCR product cloning vectors pT7Blue(R) (Novagen), pCR-Script TM SK(+) (Stratagene) or TA vector (Invitrogen) before sequence analysis, or were directly sequenced by using ampli®cation primers in the Sequenase PCR-product sequencing kit (USB) according to the manufacturers protocols.
Sequence analysis
Obtained genomic inv(16) breakpoints nucleotide sequences were analysed using the computer program DNASIS (Hitachi). Homology searches of CBFB and MYH11 nucleotide sequences were performed in Genbank and searches for repetitive sequences were performed in the library of repeats (Pythia, Jurka et al., 1997) using the BLASTN algorithm (Altschul et al., 1990) .
Note added in proof
During the preparation of this report it came to our attention that the entire genomic MYH11 sequence has been deposited in GenBank (accession nr AF001548). The CBFB sequences presented in this report have been deposited in GenBank (accession numbers: AF084955 ± AF084970).
